Literature DB >> 18442706

Advances in collagen cross-link analysis.

David R Eyre1, Mary Ann Weis, Jiann-Jiu Wu.   

Abstract

The combined application of ion-trap mass spectrometry and peptide-specific antibodies for the isolation and structural analysis of collagen cross-linking domains is illustrated with examples of results from various types of collagen with the emphasis on bone and cartilage. We highlight the potential of such methods to advance knowledge on the importance of post-translational modifications (e.g., degrees of lysine hydroxylation and glycosylation) and preferred intermolecular binding partners for telopeptide and helical cross-linking domains in regulating cross-link type and placement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442706      PMCID: PMC2398701          DOI: 10.1016/j.ymeth.2008.01.002

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  30 in total

1.  Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone.

Authors:  D A Hanson; D R Eyre
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

Review 2.  Bone biomarkers as tools in osteoporosis management.

Authors:  D R Eyre
Journal:  Spine (Phila Pa 1976)       Date:  1997-12-15       Impact factor: 3.468

3.  Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover.

Authors:  L J Beardsworth; D R Eyre; I R Dickson
Journal:  J Bone Miner Res       Date:  1990-07       Impact factor: 6.741

4.  CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta.

Authors:  Roy Morello; Terry K Bertin; Yuqing Chen; John Hicks; Laura Tonachini; Massimiliano Monticone; Patrizio Castagnola; Frank Rauch; Francis H Glorieux; Janice Vranka; Hans Peter Bächinger; James M Pace; Ulrike Schwarze; Peter H Byers; MaryAnn Weis; Russell J Fernandes; David R Eyre; Zhenqiang Yao; Brendan F Boyce; Brendan Lee
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

5.  The 10+4 microfibril structure of thin cartilage fibrils.

Authors:  David F Holmes; Karl E Kadler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

Review 6.  Articular cartilage collagen: an irreplaceable framework?

Authors:  D R Eyre; M A Weis; J-J Wu
Journal:  Eur Cell Mater       Date:  2006-11-02       Impact factor: 3.942

7.  Cross-linking and stereospecific structure of collagen in mineralized and nonmineralized skeletal tissues.

Authors:  M Yamauchi; E P Katz; K Otsubo; K Teraoka; G L Mechanic
Journal:  Connect Tissue Res       Date:  1989       Impact factor: 3.417

8.  Structural analysis of cross-linking domains in cartilage type XI collagen. Insights on polymeric assembly.

Authors:  J J Wu; D R Eyre
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

9.  Type V collagen controls the initiation of collagen fibril assembly.

Authors:  Richard J Wenstrup; Jane B Florer; Eric W Brunskill; Sheila M Bell; Inna Chervoneva; David E Birk
Journal:  J Biol Chem       Date:  2004-09-21       Impact factor: 5.157

10.  A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine.

Authors:  D A Hanson; M A Weis; A M Bollen; S L Maslan; F R Singer; D R Eyre
Journal:  J Bone Miner Res       Date:  1992-11       Impact factor: 6.741

View more
  66 in total

1.  Polymerization and matrix physical properties as important design considerations for soluble collagen formulations.

Authors:  S T Kreger; B J Bell; J Bailey; E Stites; J Kuske; B Waisner; S L Voytik-Harbin
Journal:  Biopolymers       Date:  2010-08       Impact factor: 2.505

Review 2.  Basic Biology of Extracellular Matrix in the Cardiovascular System, Part 1/4: JACC Focus Seminar.

Authors:  Gonzalo Del Monte-Nieto; Jens W Fischer; Daniel J Gorski; Richard P Harvey; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

3.  Nanomechanics of collagen microfibrils.

Authors:  Simone Vesentini; Alberto Redaelli; Alfonso Gautieri
Journal:  Muscles Ligaments Tendons J       Date:  2013-05-21

4.  Glycosylation and cross-linking in bone type I collagen.

Authors:  Masahiko Terajima; Irina Perdivara; Marnisa Sricholpech; Yoshizumi Deguchi; Nancy Pleshko; Kenneth B Tomer; Mitsuo Yamauchi
Journal:  J Biol Chem       Date:  2014-06-23       Impact factor: 5.157

Review 5.  The role of collagen crosslinks in ageing and diabetes - the good, the bad, and the ugly.

Authors:  Jess G Snedeker; Alfonso Gautieri
Journal:  Muscles Ligaments Tendons J       Date:  2014-11-17

Review 6.  Fell Muir Lecture: Collagen fibril formation in vitro and in vivo.

Authors:  Karl E Kadler
Journal:  Int J Exp Pathol       Date:  2017-05-16       Impact factor: 1.925

7.  Molecular properties and fibril ultrastructure of types II and XI collagens in cartilage of mice expressing exclusively the α1(IIA) collagen isoform.

Authors:  Audrey McAlinden; Geoffrey Traeger; Uwe Hansen; Mary Ann Weis; Soumya Ravindran; Louisa Wirthlin; David R Eyre; Russell J Fernandes
Journal:  Matrix Biol       Date:  2013-10-07       Impact factor: 11.583

8.  Increased Durability of Resin-Dentin Bonds Following Cross-Linking Treatment.

Authors:  D L S Scheffel; C C Delgado; D G Soares; F G Basso; C A de Souza Costa; D H Pashley; J Hebling
Journal:  Oper Dent       Date:  2015-03-12       Impact factor: 2.440

9.  A copper sulfate and hydroxylysine treatment regimen for enhancing collagen cross-linking and biomechanical properties in engineered neocartilage.

Authors:  Eleftherios A Makris; Regina F MacBarb; Donald J Responte; Jerry C Hu; Kyriacos A Athanasiou
Journal:  FASEB J       Date:  2013-03-01       Impact factor: 5.191

10.  Location of 3-hydroxyproline residues in collagen types I, II, III, and V/XI implies a role in fibril supramolecular assembly.

Authors:  Mary Ann Weis; David M Hudson; Lammy Kim; Melissa Scott; Jiann-Jiu Wu; David R Eyre
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.